MetaCap

Eledon Pharmaceuticals (ELDN) vs ProQR Therapeutics N.V. (PRQR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Eledon Pharmaceuticals (ELDN) has outperformed ProQR Therapeutics N.V. (PRQR) over the past year, gaining 23.6% versus a loss of 49.5%. Over five years, ELDN leads with a -65.6% price change compared with -85.5% for PRQR. Eledon Pharmaceuticals is the larger company by market cap ($150.3 million vs $147.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELDN+23.61%PRQR-49.51%
+204%+71%-62%
Nov 21, 20251 yearNov 20, 2026
ELDN-66.48%PRQR-86.62%
+10%-43%-97%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELDN versus PRQR key metrics
MetricELDNPRQR
Share price$1.78$1.04
Market cap$150.34M$146.98M
1-day change-6.32%-0.95%
YTD return+17.88%-48.51%
1-year return+23.61%-49.51%
5-year return-65.64%-85.54%
EPS (TTM)$-0.73$-0.43
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-45.62M—
52-week high$4.49$2.49
52-week low$1.39$1.00
Distance from 52-week high-60.36%-58.15%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+405.62%+626.92%
Average volume931.77K793.64K
Shares outstanding84.46M141.33M
Employees33186
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ELDN has outperformed PRQR by 73.1 percentage points over the past year.

About Eledon Pharmaceuticals

ELDN stock →

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.

Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees

About ProQR Therapeutics N.V.

PRQR stock →

ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs.

Health Care · Biotechnology: Pharmaceutical Preparations · 186 employees

ELDN vs PRQR FAQ

Which is bigger, Eledon Pharmaceuticals or ProQR Therapeutics N.V.?

Eledon Pharmaceuticals (ELDN) is larger, with a market capitalization of $150.34M compared with $146.98M for ProQR Therapeutics N.V. (PRQR).

Which stock has performed better over the past year, ELDN or PRQR?

ELDN returned +23.61% over the past 12 months, compared with -49.51% for PRQR (price return, excluding dividends). Past performance does not predict future results.

Are Eledon Pharmaceuticals and ProQR Therapeutics N.V. in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons